相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A fresh look at coronary microembolization
Petra Kleinbongard et al.
NATURE REVIEWS CARDIOLOGY (2022)
Targeting cardiovascular inflammation: next steps in clinical translation
Patrick R. Lawler et al.
EUROPEAN HEART JOURNAL (2021)
Inflammation, Infection and Venous Thromboembolism
Meaghan E. Colling et al.
CIRCULATION RESEARCH (2021)
Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure
Sarah Karam et al.
CIRCULATION (2020)
Myocardial ischaemia-reperfusion injury and cardioprotection in perspective
Gerd Heusch
NATURE REVIEWS CARDIOLOGY (2020)
Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
Ramadan A. Ali et al.
NATURE COMMUNICATIONS (2019)
The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury
Liyuan Zhu et al.
NATURE COMMUNICATIONS (2019)
A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling
Eirini Vagena et al.
TRANSLATIONAL PSYCHIATRY (2019)
Optimized Treatment of ST-Elevation Myocardial Infarction The Unmet Need to Target Coronary Microvascular Obstruction as Primary Treatment Goal to Further Improve Prognosis
Giampaolo Niccoli et al.
CIRCULATION RESEARCH (2019)
Coronary microvascular obstruction: the new frontier in cardioprotection
Gerd Heusch
BASIC RESEARCH IN CARDIOLOGY (2019)
Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models
Nonantzin Beristain-Covarrubias et al.
FRONTIERS IN IMMUNOLOGY (2019)
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury JACC Review Topic of the Week
Sean M. Davidson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo et al.
NATURE REVIEWS CARDIOLOGY (2018)
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Hmwe Hmwe Kyu et al.
LANCET (2018)
Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials
Suzanne de Waha et al.
EUROPEAN HEART JOURNAL (2017)
PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice
Rui Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria
Florian Gaertner et al.
CELL (2017)
Loss of Endothelial CXCR7 Impairs Vascular Homeostasis and Cardiac Remodeling After Myocardial Infarction Implications for Cardiovascular Drug Discovery
Huifeng Hao et al.
CIRCULATION (2017)
Relationship Between Infarct Size and Outcomes Following Primary PCI Patient-Level Analysis From 10 Randomized Trials
Gregg W. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
PDE3, but not PDE4, reduces β1- and β2-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients
Peter Molenaar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD
William B. White et al.
CHEST (2013)
Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD
Kensei Komatsu et al.
NATURE COMMUNICATIONS (2013)
PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease
J. M. Michalski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models
Alexander Brill et al.
BLOOD (2011)
Mechanisms of disease: Myocardial reperfusion injury
Derek M. Yellon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cardioprotection induced by olprinone, a phosphodiesterase III inhibitor, involves phosphatidylinositol-3-OH kinase-Akt and a mitochondrial permeability transition pore during early reperfusion
Shinya Tosaka et al.
JOURNAL OF ANESTHESIA (2007)
Vardenafil:: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial KATP channels in rabbits
FN Salloum et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
J Vinten-Johansen
CARDIOVASCULAR RESEARCH (2004)
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
SLC Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I
M Napoletano et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
分享论文
